GSKWayne, PA, United States
Interested in SLE, APS, SSc and other systemic autoimmune disorders.
0587: Impact of up to 24 Months Intravenous (IV) Belimumab (BEL) Treatment on Steroid Use and Disease Activity in Patients with SLE in Clinical Practice: Additional Post Hoc Pooled Analysis of Multicountry OBSErve Cohort Data
Sunday, November 12, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.
